Rachel Thorn


+1 212 479 6465

Rachel Thorn focuses on international commercial arbitration, investment treaty disputes and international litigation. Rachel has successfully represented corporate clients, states and state-owned entities in both commercial and investment treaty arbitrations conducted under the major arbitration rules in forums around the world. She has extensive experience in disputes involving the energy, construction and life sciences sectors, as well as post M&A disputes and disputes concerning joint ventures and long-term cooperation agreements, concession contracts, production sharing and offtake agreements.

Download full bio 


  • Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million 

  • X4 Pharmaceuticals in its Exclusive License Agreement with Abbisko Therapeutics 

  • Forty Seven in its Exclusive License Agreement with Ono Pharmaceutical 

  • GENFIT SA in its Licensing and Collaboration Agreement with Terns Pharmaceuticals 

  • I-Mab Enters Global Strategic Partnership With AbbVie for Cancer Treatment 


  • University of Chicago Law School
    JD, 1996

  • University of Wisconsin, Madison
    BA, 1992

Admissions & Credentials

New York

England & Wales

Rankings & Accolades

    Legal 500 US: International Arbitration

    Benchmark Litigation: Future Star (2014)

    Global Arbitration Review: Top 45 Under 45 (2011)


+1 212 479 6465 office

55 Hudson Yards
New York, NY 10001-2157